Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.13143
Abstract: We describe here a case of nivolumab‐induced type 1 diabetes, which developed within 9 days of treatment. The case highlights the importance of frequent monitoring of glucose after initiation of nivolumab treatment. read more here.
Keywords: fulminant type; induced fulminant; diabetes precipitous; type diabetes ... See more keywords